Abbott Laboratories (ABT)
117.76
+0.50
(+0.43%)
USD |
NYSE |
Nov 22, 16:00
117.76
0.00 (0.00%)
Pre-Market: 20:00
Abbott Laboratories Cash from Investing (Quarterly): -594.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -594.00M |
| June 30, 2024 | -453.00M |
| March 31, 2024 | -425.00M |
| December 31, 2023 | -824.00M |
| September 30, 2023 | -634.00M |
| June 30, 2023 | -1.213B |
| March 31, 2023 | -462.00M |
| December 31, 2022 | -632.00M |
| September 30, 2022 | -484.00M |
| June 30, 2022 | -264.00M |
| March 31, 2022 | -360.00M |
| December 31, 2021 | -671.00M |
| September 30, 2021 | -651.00M |
| June 30, 2021 | -264.00M |
| March 31, 2021 | -422.00M |
| December 31, 2020 | -731.00M |
| September 30, 2020 | -472.00M |
| June 30, 2020 | -619.00M |
| March 31, 2020 | -393.00M |
| December 31, 2019 | -489.00M |
| September 30, 2019 | -432.00M |
| June 30, 2019 | -498.00M |
| March 31, 2019 | -396.00M |
| December 31, 2018 | -496.00M |
| September 30, 2018 | -323.00M |
| Date | Value |
|---|---|
| June 30, 2018 | -299.00M |
| March 31, 2018 | -238.00M |
| December 31, 2017 | -3.152B |
| September 30, 2017 | -306.00M |
| June 30, 2017 | -6.00M |
| March 31, 2017 | -6.154B |
| December 31, 2016 | 1.55B |
| September 30, 2016 | -554.00M |
| June 30, 2016 | -1.47B |
| March 31, 2016 | 226.00M |
| December 31, 2015 | 1.566B |
| September 30, 2015 | -1.197B |
| June 30, 2015 | 242.00M |
| March 31, 2015 | -205.00M |
| December 31, 2014 | -10.00M |
| September 30, 2014 | -825.00M |
| June 30, 2014 | 1.228B |
| March 31, 2014 | -595.00M |
| December 31, 2013 | 840.00M |
| September 30, 2013 | -2.697B |
| June 30, 2013 | 36.00M |
| March 31, 2013 | -2.108B |
| December 31, 2012 | -1.225B |
| September 30, 2012 | -131.61M |
| June 30, 2012 | 688.37M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.213B
Minimum
Jun 2023
-264.00M
Maximum
Jun 2021
-552.85M
Average
-486.50M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Becton Dickinson & Co | -3.937B |
| ResMed Inc | 2.146M |
| QuidelOrtho Corp | -56.50M |
| iRhythm Technologies Inc | -55.33M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.705B |
| Cash from Financing (Quarterly) | -1.576B |
| Free Cash Flow | 6.486B |
| Free Cash Flow Per Share (Quarterly) | 1.230 |
| Free Cash Flow to Equity (Quarterly) | 1.924B |
| Free Cash Flow to Firm (Quarterly) | 2.192B |
| Free Cash Flow Yield | 3.15% |